Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials.
Literature Commentary.
Body mass index during adolescence, rather than childhood, is critical in determining MS risk.
P2X4 receptors control the fate and survival of activated microglia.
Cost effectiveness of Sativex for spasticity in multiple sclerosis.
Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their health.
Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Mechanisms of sodium channel clustering and its influence on axonal impulse conduction.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Csf analysis and the diagnosis of neuromyelitis optica.
HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Iron chelation in the treatment of neurodegenerative diseases.
Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Short-term effects of prolonged fasting on multiple sclerosis.
Invisible Killers.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Longitudinally extensive transverse myelitis associated with dengue fever.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Self-report assessment of fatigue in multiple sclerosis: a critical evaluation.
Systematic review of pharmacologic therapies for neuropathic pain associated with stroke, HIV, trauma, and multiple sclerosis.
Neuromyelitis optica spectrum disorder associated with osmotic demyelination syndrome.
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis.
Pages
« first
‹ previous
…
602
603
604
605
606
607
608
609
610
…
next ›
last »